| Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications C Corrado, S Raimondo, A Chiesi, F Ciccia, G De Leo, R Alessandro International journal of molecular sciences 14 (3), 5338-5366, 2013 | 462 | 2013 |
| Brief report: intestinal dysbiosis in ankylosing spondylitis ME Costello, F Ciccia, D Willner, N Warrington, PC Robinson, B Gardiner, ... Arthritis & rheumatology 67 (3), 686-691, 2015 | 458 | 2015 |
| Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis N Tajik, M Frech, O Schulz, F Schälter, S Lucas, V Azizov, K Dürholz, ... Nature communications 11 (1), 1995, 2020 | 359 | 2020 |
| Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis F Ciccia, G Guggino, A Rizzo, L Saieva, S Peralta, AR Giardina, ... Annals of the rheumatic diseases 74 (9), 1739-1747, 2015 | 311 | 2015 |
| Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with … G Triolo, A Ferrante, F Ciccia, A Accardo‐Palumbo, A Perino, A Castelli, ... Arthritis & Rheumatism 48 (3), 728-731, 2003 | 295 | 2003 |
| Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis F Ciccia, G Guggino, A Rizzo, R Alessandro, MM Luchetti, S Milling, ... Annals of the rheumatic diseases 76 (6), 1123-1132, 2017 | 288 | 2017 |
| Overexpression of interleukin‐23, but not interleukin‐17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis F Ciccia, M Bombardieri, A Principato, AR Giardina, C Tripodo, R Porcasi, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 278 | 2009 |
| The gut–joint axis in rheumatoid arthritis MM Zaiss, HJ Joyce Wu, D Mauro, G Schett, F Ciccia Nature Reviews Rheumatology 17 (4), 224-237, 2021 | 233 | 2021 |
| Role of the IL-23/IL-17 pathway in rheumatic diseases: an overview C Schinocca, C Rizzo, S Fasano, G Grasso, L La Barbera, F Ciccia, ... Frontiers in immunology 12, 637829, 2021 | 231 | 2021 |
| Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study F Carubbi, P Cipriani, A Marrelli, PD Benedetto, P Ruscitti, O Berardicurti, ... Arthritis research & therapy 15, 1-15, 2013 | 221 | 2013 |
| Ankylosing spondylitis: an autoimmune or autoinflammatory disease? D Mauro, R Thomas, G Guggino, R Lories, MA Brown, F Ciccia Nature Reviews Rheumatology 17 (7), 387-404, 2021 | 196 | 2021 |
| Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut … F Ciccia, A Accardo-Palumbo, A Rizzo, G Guggino, S Raimondo, ... Annals of the rheumatic diseases 73 (8), 1566-1574, 2014 | 193 | 2014 |
| Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome F Ciccia, G Guggino, A Rizzo, A Ferrante, S Raimondo, AR Giardina, ... Annals of the rheumatic diseases 71 (2), 295-301, 2012 | 186 | 2012 |
| Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers P Ruscitti, P Cipriani, F Masedu, D Iacono, F Ciccia, V Liakouli, ... BMC medicine 14, 1-11, 2016 | 174 | 2016 |
| Interleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis F Ciccia, A Accardo‐Palumbo, R Alessandro, A Rizzo, S Principe, ... Arthritis & Rheumatism 64 (6), 1869-1878, 2012 | 143 | 2012 |
| International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis … R Giacomelli, A Afeltra, A Alunno, C Baldini, E Bartoloni-Bocci, ... Autoimmunity Reviews 16 (9), 911-924, 2017 | 140 | 2017 |
| Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding … P Ruscitti, P Cipriani, P Di Benedetto, V Liakouli, O Berardicurti, F Carubbi, ... Clinical & Experimental Immunology 182 (1), 35-44, 2015 | 137 | 2015 |
| IL-34 is overexpressed in the inflamed salivary glands of patients with Sjögren’s syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16 … F Ciccia, R Alessandro, V Rodolico, G Guggino, S Raimondo, ... Rheumatology 52 (6), 1009-1017, 2013 | 137 | 2013 |
| Interstitial lung disease in systemic sclerosis: current and future treatment R Giacomelli, V Liakouli, O Berardicurti, P Ruscitti, P Di Benedetto, ... Rheumatology international 37, 853-863, 2017 | 122 | 2017 |
| Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis F Ciccia, G Guggino, A Rizzo, A Manzo, B Vitolo, MP La Manna, ... Rheumatology 54 (12), 2264-2272, 2015 | 115 | 2015 |
Antonio CraxiFull Professor of Gastroenterology and Internal Medicine, PROMISE, University of Palermo, Italy在 unipa.it 的电子邮件经过验证
Antonio CraxiFull Professor of Gastroenterology and Internal Medicine, PROMISE, University of Palermo, Italy在 unipa.it 的电子邮件经过验证